A placebo-controlled (sham surgery) trial of VY-AADC01 in patients with advanced Parkinson's disease

Trial Profile

A placebo-controlled (sham surgery) trial of VY-AADC01 in patients with advanced Parkinson's disease

Planning
Phase of Trial: Phase II

Latest Information Update: 10 May 2017

At a glance

  • Drugs AAV-hAADC (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 May 2017 According to a Voyager Therapeutics media release, data from two studies (CTP700238664 & CTP700238664) will help inform the design of this trial.
    • 23 Nov 2016 New trial record
    • 10 Nov 2016 According to Voyager Therapeutics, compnay planned to begin this trial in the fourth quarter of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top